Showing results (1-10 of 270) with videos related to
Sort By:
Pageof 27
International Journal of Cancer|September 15, 1983
Purification of a protein (60K/58K) associated with the Epstein-Barr virus-induced early antigen complex in Raji cellsG Dölken, W Lange, U Weitzmann, et al.Journal of Immunological Methods|March 16, 1984
Enzyme-linked immunosorbent assay for IgG antibodies to Epstein-Barr virus-associated early antigens and viral capsid antigenG Dölken, U Weitzmann, C Boldt, et al.Journal of Immunological Methods|March 30, 1984
Detection of IgA antibodies to Epstein-Barr virus-associated antigens by ELISAG Dölken, U Weitzmann, C Boldt, et al.Cancer Detection and Prevention|January 1, 1983
Enzyme-linked immunosorbent assay for antibodies to Epstein-Barr virus-associated early antigens and the viral capsid antigenG Dölken, C Boldt, W Lange, et al.FEBS Letters|January 31, 1994
Comparison of different ribozymes for efficient and specific cleavage of BCR/ABL related mRNAsW Lange, M Daskalakis, J Finke, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 1, 1993
Persistence of circulating t(14;18)-positive cells in long-term remission after radiation therapy for localized-stage follicular lymphomaJ Finke, J Slanina, W Lange, et al.Leukemia & Lymphoma|February 1, 1994
BCL-2 induction is part of the strategy of Epstein-Barr virusJ Finke, W Lange, R Mertelsmann, et al.Virology|January 15, 1986
Purification of a polypeptide complex (p52) belonging to the D-subspecificites of Epstein-Barr virus-induced early antigensG Dölken, T Hecht, U Weitzmann, et al.Leukemia|November 1, 1993
In vitro and in vivo effects of synthetic ribozymes targeted against BCR/ABL mRNAW Lange, E M Cantin, J Finke, et al.Biotechniques|March 1, 1993
An improved strategy and a useful housekeeping gene for RNA analysis from formalin-fixed, paraffin-embedded tissues by PCRJ Finke, R Fritzen, P Ternes, et al.Pageof 27